This study was performed to examine the combined effects of L-carnitine and isoflavone supplementation on weight reduction and body fat distribution in overweight women. Overweight/obese women (body mass index > 23 ㎏/㎡) who were not diagnosed an...
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A82576615
2007
Korean
590
KCI등재,SCOPUS
학술저널
630-638(9쪽)
5
0
상세조회0
다운로드다국어 초록 (Multilingual Abstract)
This study was performed to examine the combined effects of L-carnitine and isoflavone supplementation on weight reduction and body fat distribution in overweight women. Overweight/obese women (body mass index > 23 ㎏/㎡) who were not diagnosed an...
This study was performed to examine the combined effects of L-carnitine and isoflavone supplementation on weight reduction and body fat distribution in overweight women. Overweight/obese women (body mass index > 23 ㎏/㎡) who were not diagnosed any type of diseases were included in this study and sixty subjects (41.1 ± 1.5 years, 25.9 ± 0.3 ㎏/㎡) were randomly assigned to a placebo (n = 30) or a supplement group (n = 30, L-carnitine 300 ㎎+isoflavone 40 ㎎/day). We measured anthropometric parameters, abdominal fat distribution by computerizd tomography and blood components before and after the 12 week intervention period. After the 12 weeks of supplementation, subjects in L-car-nitine and isoflavone supplement group showed a significant reduction of body weight (p < 0.001), body fat % (p < 0.05), and waist to hip ratio (p < 0.01) whereas placebo group did not show any changes. In a CT-scanned results, total fat area at L4 level was significantly reduced by 8.1 % (p < 0.01) with the reduction of visceral fat area (-11.1 %, p < 0.001) and subcutaneous fat area (-7.0%, p < 0.05) in the supplement group. The supplementation of L-carnitine and isoflavone showed the significant improvement of HDL-C (p < 0.01) and apoB (p < 0.05) concentrations, however, change values in those markers were not significant compared with those of the placebo group. In addition, a significant increase of adiponectin level (p < 0.001) was observed in the supplement group after the intervention. The result of present study demonstrated that supplementation of 300 ㎎ L-carnitine and 40 mg isoflavone per day for 12 weeks can give beneficial effects on weight reduction and visceral fat accumulation. These potential antiobesity supplement can produce more favorable effects when combined with lifestyle modification.
목차 (Table of Contents)
참고문헌 (Reference)
1 Lofgren IE, "Weight loss favorably modifies anthropometrics and reverses the metabolic syndrome in premenopausal women" 24 (24): 486-493, 2005
2 Borradaile NM, "The soy phytoestrogens, genistein and daidzein, reduce apolipoprotein B secretion from HepG2 cells through multiple mechanisms" 366 : 531-539, 2002
3 Yamauchi T, "The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obestiy" 7 : 941-946, 2001
4 Dewell A, "The effects of soy-derived phytoestrogen on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women" 87 : 118-121, 2002
5 Owen A, "The effect of isoflavone supplementation on serum lipids in postmenopausal women" 27 : A232-, 2000
6 Wutzke KD, "The effect of L-carnitine on fat oxidation and body compositon in slightly overweight subjucts" 53 (53): 1002-1006, 2004
7 Taku K, "Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials" 85 : 1148-1156, 2007
8 Nestel PJ, "Soy isoflavones improve systemic compliance but not plasma lipids in menopausal and preimenopausal women" 17 (17): 3392-3398, 1997
9 Mori M, "Soy isoflavone tablets reduce osteoporosis risk factors and obesity in middleaged Japanese women" 31 (31): S39-2, 2004
10 Shin ES, "Positive regulation of hepatic carnitine palmitoyl transferase 1A (CPT1A) activities by soy isoflavones and L-carnitine" 45 (45): 159-164, 2006
1 Lofgren IE, "Weight loss favorably modifies anthropometrics and reverses the metabolic syndrome in premenopausal women" 24 (24): 486-493, 2005
2 Borradaile NM, "The soy phytoestrogens, genistein and daidzein, reduce apolipoprotein B secretion from HepG2 cells through multiple mechanisms" 366 : 531-539, 2002
3 Yamauchi T, "The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obestiy" 7 : 941-946, 2001
4 Dewell A, "The effects of soy-derived phytoestrogen on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women" 87 : 118-121, 2002
5 Owen A, "The effect of isoflavone supplementation on serum lipids in postmenopausal women" 27 : A232-, 2000
6 Wutzke KD, "The effect of L-carnitine on fat oxidation and body compositon in slightly overweight subjucts" 53 (53): 1002-1006, 2004
7 Taku K, "Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials" 85 : 1148-1156, 2007
8 Nestel PJ, "Soy isoflavones improve systemic compliance but not plasma lipids in menopausal and preimenopausal women" 17 (17): 3392-3398, 1997
9 Mori M, "Soy isoflavone tablets reduce osteoporosis risk factors and obesity in middleaged Japanese women" 31 (31): S39-2, 2004
10 Shin ES, "Positive regulation of hepatic carnitine palmitoyl transferase 1A (CPT1A) activities by soy isoflavones and L-carnitine" 45 (45): 159-164, 2006
11 Ryan AS, "Plasma adiponectin and leptin levels. body composition, and glucose utilization in adult women with wide ranges of age and obesity" 26 : 2383-2388, 2003
12 Park HW, "Long Term Feeding with Soy Isoflavone and L-Carnitine synergistically suppresses body weight gain and adiposity in highfat diet induced obese mice" 9 (9): 179-189, 2006
13 Villani RG, "L-carnitine supplement combined with aerobic traning dose no promote weight loss in moderately obese women" 10 : 99-, 2000
14 Nestel PJ, "Isoflavones from red clover improve systemic compliance but not plasma lipids in menopausal women" 84 : 895-898, 1999
15 Kuiper GG, "Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta" 139 (139): 4252-4263, 1998
16 Matsuzawa Y. Adiponectin, "Identification, physiology and clinical relevance in metabolic and vascular disease" 6 (6): 7-14, 2005
17 Weyer C, "Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia" 86 : 1930-1935, 2001
18 Kim SJ, "Hepatic gene expression profiles are altered by genistein supplementation in mice with diet-induced obesity" 135 (135): 33-41, 2005
19 Them DM, "Haskell WL. Potential health benefits of dietary phytoestrogens a review of the clinical" 2223-2235,
20 Kim S, "Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPAR alpha" 220 (220): 51-58, 2004
21 Kim HK, "Genistein decreases food intake, body weight, and fat pad weight and causes adipose tissue apoptosis in ovariectomized female mice" 136 (136): 409-414, 2006
22 Szkudelski T, "Genistein affects lipogenesis and lipolysis in isolated rat adipocytes" 75 : 265-271, 2000
23 Levy RI, "Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972" 499-502,
24 Muller DM, "Effects of oral L-carnitine supplementation on in vivo long-chain fatty acid oxidation in healthy adults" 51 (51): 1389-1391, 2002
25 Kopp HP, "Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women" 29 : 766-771, 2005
26 Wu J, "Effects of Isoflavone and exercise on BMD and fat mass in postmenopausal japanese women: A 1-year randomized placebo-controlled trial" 21 (21): 780-789, 2006
27 Yang JY, "Effect of genistein with carnitine administration on lipid parameters and obesity in C57Bl/ 6J mice fed a high-fat diet" 9 (9): 459-467, 2006
28 Kim JK, "Effect of Lysine-limited diers containing different levels of L-carnitine on body weight and lipid metabolism in obesity-induced adult rats" 40 (40): 118-129, 2007
29 Elisaf M, "Effect of L-carnitine supplimentation on lipid parameters in hemodialysis patients" 18 : 416-421, 1998
30 Argani H, "Effect of L-carnitine on the serum lipoprotein and HDL-C subclasses in hemodialysis patients" 101 : C174-C179, 2005
31 Wu J, "Combined intervention of soy isoflavone and moderate exercise prevents body fat elevation and bone loss in ovariectomized mice" 53 (53): 942-948, 2004
32 Bhathena SJ, "Beneficial role of dietary phytoestrogens in obesity and diabetes" 76 (76): 1191-1201, 2002
33 Uesugi T, "Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: A four week study" 21 : 97-102, 2002
34 Ministry of Health and Welfare, "2005 National health and nutrition survey, overview" 2006
35 Ministry of Health and Welfare, "1998 National health and nutrition survey, overview" 1999
고지방식이 흰쥐에서 산초나무 Butanol 및 Methylene Chloride분획의 항혈전 및 항염증 작용
대학 운동선수들의 음료 섭취실태 및 수분 섭취 관련 영양지식에 관한 연구
남녀 노인층에서 Alzheimer 위험 예측 인자로써의 Apo E4 Genotype에 관한 연구
난소절제 칼슘결핍 흰쥐에서 칼슘과 마그네슘의 보충이 혈액과 간의 지질함량에 미치는 영향
학술지 이력
연월일 | 이력구분 | 이력상세 | 등재구분 |
---|---|---|---|
2023 | 평가예정 | 해외DB학술지평가 신청대상 (해외등재 학술지 평가) | |
2020-01-01 | 평가 | 등재학술지 유지 (해외등재 학술지 평가) | |
2013-07-24 | 학술지명변경 | 한글명 : 한국영양학회지 -> Journal of Nutrition and Health외국어명 : The Korean Journal of Nutrition -> Journal of Nutrition and Health | |
2010-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2008-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2006-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2001-01-01 | 평가 | 등재학술지 선정 (등재후보2차) | |
1998-07-01 | 평가 | 등재후보학술지 선정 (신규평가) |
학술지 인용정보
기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
---|---|---|---|
2016 | 0.86 | 0.86 | 1.03 |
KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
1.18 | 1.11 | 1.778 | 0.12 |